All abstracts
Home
Scientific Programme
Industry Sessions
Live Sessions
Abstracts
E-posters
Sponsors and Exhibitors
All
Posters
Topics
Presentation Type
Loading
Clear all filters
EPP001
A randomised, single-blind, sham-controlled clinical trial on the effects of intermittent Theta-Burst Stimulation (iTBS) on depressive and cognitive symptoms in patients with Treatment-Resistant Depression.
EPP002
The Association Between Depression and Headache Characteristics in Adults
EPP003
Effectiveness of Cognitive Remediation in Subjects with Major Depressive Disorder: 3-Month Follow-Up Results of a Multicenter Randomized Controlled Study
EPP004
Personality Disorders and Clinical Response to Intranasal Esketamine in Treatment-Resistant Depression: Trajectories, Modulations, and Psychopatologic Reflections
EPP005
Like Stepping Outside the Noise: Narrative Experiences of Esketamine-Induced Dissociation in Patients with Treatment-Resistant Depression
EPP006
Patient and Family Determinants of Caregiver Burden in Major Depressive Disorder: A Multicenter Observational Study
EPP007
The efficacy of transcranial direct current stimulation (tDCS) combined with cognitive behavioural therapy for major depressive disorder: a systematic review and meta-analysis of randomised controlled trials.
EPP008
Early Treatment and Functional Recovery in Treatment-Resistant Depression: Real-World Evidence from Intranasal Esketamine in Spain
EPP009
Intranasal Esketamine for Treatment-Resistant Depression in Real-World Multicenter Practice: Clinical Effectiveness, Functional Recovery, and Patient-Reported Quality of Life
EPP010
Cariprazine as a transdiagnostic treatment for symptoms of depression across different disorders
EPP011
Bidirectional Associations Between Highly Processed Food Consumption and Major Depressive Disorder: A Cross-Sectional Study on Adults Residing in Madrid and Barcelona (Edad con Salud)
EPP012
Genome-Wide DNA Methylation Analysis Reveals Epigenetic Signatures of Early Life Stress in Major Depressive Disorder Patients
EPP013
Efficacy and Safety of Adjunctive Lumateperone 42 mg in Major Depressive Disorder: A Pooled Analysis of Demographic and Clinical Subgroups from 2 Phase 3 Randomized Placebo-Controlled Trials
EPP014
Care Next Door: Community Outpatient Esketamine Across Urban and Rural Clinics
EPP015
ECHO: Results from a Non-Interventional Cohort Study of Esketamine Nasal Spray in Treatment Resistant Depression
EPP016
Efficacy of Probiotic Supplementation with Lactobacillus and Bifidobacterium in Major Depressive Disorder: A Meta-analysis of Randomized Controlled Trials
EPP017
Predictors of Sexual Dysfunction in Unipolar Depression: A Register-Based Nested Case-Control Study
EPP018
Lithium Prescription in Unipolar Depression: Findings from a Nationwide Greek Cohort Study
EPP019
Thyroid Function and Mood Disorders: From Etiology to Treatment Response
EPP020
What Outcomes Matter in Recovery in Depression?: Cross-sectional Sample of Individuals with Major Depressive Disorder in a Diverse, Safety-net Setting
1864
abstracts
1
2
...
94